CDKN2B-AS1 and neoplasm: Huang et al reported that lncRNA CDKN2B antisense RNA 1 (CDKN2B‐AS1) positively regulated tumour growth and microvascular invasion, representing high tumour grade and reduced survival of HCC patients.